CLINICAL_TRIALS
trial_result
· 2013-10-11
Clinical Trial Update: Research Study for Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Summary
A Phase 2 clinical trial for metastatic renal cell carcinoma sponsored by Bayer has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Bayer | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: TERMINATED